Anápolis, Brazil

The production site in Anápolis (state of Goiás), located in the second biggest hub of pharmaceutical industry in Brazil, was founded in 1994 as a specialist for small volume parenterals and acquired by Fresenius Kabi in 2014. The facility has 6 dedicated production areas according to technologies used and therapeutical class of the final product. The plant produces a variety of small volume parenterals, i.e. liquids (glass ampoules 1-10 ml) and powders (glass vials 0.1-4.5 g) through aseptic processing or final sterilization focusing on Antibiotics, Glucocorticoids, Analgesics and Catecholamine. 

The facility employs about 500 people and has its own quality, logistics and administration departments including an onsite warehouse.

Technologies:

  • Aseptic filling
  • Terminal sterilization

Products:

  • Antibiotics
  • Glucocorticoids
  • Analgesics
  • Catecholamine

Containers:

Certificates:

  • GMP by Anvisa
  • GAFO (Grupo de Avaliação e Qualificação de Fornecedores/ Evaluation and Qualification Group for Suppliers)

Market:

  • Local and Regional